86 related articles for article (PubMed ID: 6726980)
1. Prolonged bleeding time associated with 'low-dose' moxalactam therapy.
Bach MC
JAMA; 1984 Jun; 251(23):3082. PubMed ID: 6726980
[No Abstract] [Full Text] [Related]
2. Prolonged bleeding time associated with moxalactam administration.
Fishman L; Marsh WR
Neurosurgery; 1984 Jun; 14(6):735-6. PubMed ID: 6462409
[TBL] [Abstract][Full Text] [Related]
3. Moxalactam. Evaluation of clinical bleeding in patients with abdominal infection.
Joehl RJ; Rasbach DA; Ballard JO; Weitekamp MR; Sattler FR
Arch Surg; 1983 Nov; 118(11):1259-61. PubMed ID: 6639335
[TBL] [Abstract][Full Text] [Related]
4. Prolonged bleeding times and bleeding diathesis associated with moxalactam administration.
Weitekamp MR; Aber RC
JAMA; 1983 Jan; 249(1):69-71. PubMed ID: 6217353
[No Abstract] [Full Text] [Related]
5. Effects of various doses of latamoxef (moxalactam) on haemostasis.
Bowcock S; Mackie IJ; Ho D; Moulsdale M; Billings P; Machin SJ
J Hosp Infect; 1986 Sep; 8(2):193-9. PubMed ID: 2876035
[TBL] [Abstract][Full Text] [Related]
6. New beta-lactam antibiotics and hemorrhagic diathesis: comparison of moxalactam and cefotaxime.
Andrassy K; Koderisch J; Fritz S; Ritz E
Clin Ther; 1983; 6(1):34-42. PubMed ID: 6325005
[TBL] [Abstract][Full Text] [Related]
7. Coagulopathy associated with the use of cephalosporin or moxalactam antibiotics in acute and chronic renal failure.
Clark J; Hochman R; Rolla AR; Thomas S; Miller DG; Kaldany A; D'Elia JA
Clin Exp Dial Apheresis; 1983; 7(3):177-90. PubMed ID: 6671350
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of halothane effect on blood coagulation and bleeding time: a study of 129 cases with elective operations.
Padmasuta K; Sangarlangkarn S; Bunyaratvej A
J Med Assoc Thai; 1987 May; 70(5):261-4. PubMed ID: 3655586
[No Abstract] [Full Text] [Related]
9. Cephalosporin induced coagulopathies.
Seeler RA; Reitan J
IMJ Ill Med J; 1984 Nov; 166(5):351-3. PubMed ID: 6150914
[No Abstract] [Full Text] [Related]
10. A study of aspirin induced changes in bleeding time, platelet aggregation, and Sonoclot coagulation analysis in humans.
Samra SK; Harrison RL; Bee DE; Valero V
Ann Clin Lab Sci; 1991; 21(5):315-27. PubMed ID: 1952780
[TBL] [Abstract][Full Text] [Related]
11. Clinical risk factors for prolonged PT/PTT in abdominal sepsis patients treated with moxalactam or tobramycin plus clindamycin.
Baxter JG; Marble DA; Whitfield LR; Wels PB; Walczak P; Schentag JJ
Ann Surg; 1985 Jan; 201(1):96-102. PubMed ID: 3966831
[TBL] [Abstract][Full Text] [Related]
12. Effect of ketanserin on bleeding time: a comparison with aspirin.
Fraitag B; Bondard I; Duloroy J; Gorin NC
Thromb Res; 1986 Oct; 44(2):261-4. PubMed ID: 3787570
[No Abstract] [Full Text] [Related]
13. Severe bleeding diathesis associated with moxalactam administration.
Meisel S
Drug Intell Clin Pharm; 1984 Sep; 18(9):721-2. PubMed ID: 6479021
[TBL] [Abstract][Full Text] [Related]
14. Enhanced bleeding with cefoxitin or moxalactam. Statistical analysis within a defined population of 1493 patients.
Brown RB; Klar J; Lemeshow S; Teres D; Pastides H; Sands M
Arch Intern Med; 1986 Nov; 146(11):2159-64. PubMed ID: 3778044
[TBL] [Abstract][Full Text] [Related]
15. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
[TBL] [Abstract][Full Text] [Related]
16. Latamoxef-induced coagulation disorders: Incidence and risk factors.
Cai Y; Zhang M; Wang Y; Wang N; Zhang L; Zhang K
J Clin Pharm Ther; 2021 Oct; 46(5):1382-1386. PubMed ID: 34114239
[TBL] [Abstract][Full Text] [Related]
17. The effects of latamoxef, cefotaxime, and cefoperazone on platelet function and coagulation in normal volunteers.
Weitekamp MR; Caputo GM; Al-Mondhiry HA; Aber RC
J Antimicrob Chemother; 1985 Jul; 16(1):95-101. PubMed ID: 4044467
[TBL] [Abstract][Full Text] [Related]
18. Moxalactam-induced hypoprothrombinemia with intrahepatic bleeding.
Sylvester RK; Bailie GR; Kravitz GR; Smith TR
Minn Med; 1984 Mar; 67(3):141-2. PubMed ID: 6738481
[No Abstract] [Full Text] [Related]
19. Empiric therapy with moxalactam alone in patients with bacteremia.
Wilson WR; Henry NK; Keys TF; Anhalt JP; Cockerill FR; Edson RS; Geraci JE; Hermans PE; Muller SM; Rosenblatt JE
Mayo Clin Proc; 1984 May; 59(5):318-26. PubMed ID: 6727424
[TBL] [Abstract][Full Text] [Related]
20. Fatal retroperitoneal bleeding following Latamoxef (Moxalactam) use.
Al-Fallouji MA; Al-Quisi NK
Br J Clin Pract; 1985 Jun; 39(6):249. PubMed ID: 4041353
[No Abstract] [Full Text] [Related]
[Next] [New Search]
